Yes, azithromycin can be given to a woman who is 2 months pregnant.
Azithromycin is classified as FDA Pregnancy Category B and is considered "probably safe" for use during pregnancy, including the first trimester (2 months gestation). 1
Evidence Supporting Use in Pregnancy
FDA Classification and Safety Profile
The FDA drug label clearly states that azithromycin is Pregnancy Category B, meaning animal reproduction studies showed no evidence of harm to the fetus at doses 2-4 times the human dose, though adequate well-controlled studies in pregnant women are lacking 1. The label concludes that azithromycin "should be used during pregnancy only if clearly needed."
Clinical Guidelines Support Use
The 2020 ERS/TSANZ guidelines on pregnancy and airways diseases classify azithromycin as "probably safe" with a B1 (TGA) and B (FDA) rating 2. This is a favorable safety profile compared to many other antibiotics. The guidelines note human data suggest low risk, though there is a very low risk of hypertrophic pyloric stenosis in infants exposed during the first 13 days of breastfeeding (not relevant to pregnancy exposure) 2.
Clinical Experience
Multiple studies demonstrate azithromycin's effectiveness and safety in pregnancy:
- A 1995 study showed 96% cure rate for chlamydial cervicitis with only 5% side effects in 146 pregnant women 3
- A 1998 study found azithromycin superior to erythromycin with substantially fewer severe side effects (7.4% vs 38.8%) 4
- CDC guidelines from 2002 and 2005 list azithromycin as an alternative regimen for chlamydial infections in pregnancy 5, 6
Important Caveats
When Azithromycin is Preferred
- For chlamydial infections: Azithromycin is preferred over erythromycin due to better tolerability and compliance 5, 4
- For pertussis: Azithromycin is the preferred macrolide, especially for infants <1 month 6
- For MAC prophylaxis in HIV: Azithromycin is preferred over clarithromycin in pregnancy due to clarithromycin's association with birth defects in animal studies 7
Conflicting Evidence to Consider
While most evidence supports safety, a 2022 review noted conflicting results regarding potential risks of spontaneous miscarriage, major congenital malformations, and preterm birth in some studies but not others 8. A 2023 animal study showed multi-organ toxicity in mice at high doses 9. However, these concerns are not reflected in clinical guidelines or FDA labeling, and the preponderance of human evidence supports safety.
Clinical Decision Framework
Use azithromycin in pregnancy when:
- There is a clear clinical indication (bacterial infection requiring treatment)
- The benefits of treating the infection outweigh theoretical risks
- The infection itself poses risk to maternal or fetal health if untreated
At 2 months (8 weeks) gestation, this is during organogenesis (first trimester), but azithromycin's Category B classification and "probably safe" designation apply to all trimesters, including early pregnancy 2, 1.
Practical Prescribing
- Standard adult dose: 500 mg on day 1, then 250 mg daily on days 2-5 6
- For chlamydia: Single 1g dose is effective and well-tolerated 5, 3, 4
- Monitor for gastrointestinal side effects (most common adverse effect) 6, 1
- No dose adjustment needed for pregnancy 1
The key principle: azithromycin should be used when clinically indicated during pregnancy, as untreated bacterial infections pose greater risk to both mother and fetus than the medication itself.